Rozanolixizumab: First Approval
This article summarizes the milestones in the development of rozanolixizumab leading to this first approval for the treatment of gMG in adults who are anti-AChR or anti-MuSK antibody positive.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Autoimmune Disease | Brain Tumor | Drugs & Pharmacology | Encephalitis | Fibromyalgia | Glioma | Japan Health | Myasthenia Gravis | Perinatology & Neonatology | Pharmaceuticals